BioRestorative Therapies BRTX
NASDAQ BRTX
$1.57 +0.04 (+2.61%)
At close: Nov 11, 2026 · 4:00 PM EST

BioRestorative Therapies (BRTX) Depreciation & Amortization (CF) (2010 - 2026)

Updated

BioRestorative Therapies (BRTX) recorded Depreciation & Amortization (CF) of $52,394 in Q1 2026, up 1.2% from $51,781 a year earlier but down 0.8% from the prior quarter.

Analysis

BioRestorative Therapies (BRTX) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

On a TTM basis, BioRestorative Therapies' Depreciation & Amortization (CF) came in at $210,598 as of Mar 31, 2026, up 6.3% year-over-year; for FY2025, it came in at $209,985, up 11.1% from FY2024.

  • Annual Depreciation & Amortization (CF) has increased for four straight years, with a five-year compound annual growth rate of 11.6% (FY2020 to FY2025).
  • Across earlier years, Depreciation & Amortization (CF) came in at $189,056 in FY2024 (+14.1%), $165,735 in FY2023 (+37.5%), $120,545 in FY2022 (+35.3%) and $89,108 in FY2021 (-26.6%).
  • Quarterly Depreciation & Amortization (CF) has ranged from $21,496 in Q4 2021 to $52,836 in Q4 2025 over the past five years.
  • On a year-over-year basis, Depreciation & Amortization (CF) has increased for 17 consecutive quarters, with growth averaging 11.8% over the last eight quarters.
  • Peak year-over-year performance for Depreciation & Amortization (CF) in the last five years was growth of 51.3% in Q1 2023, against a decline of 18.2% in Q2 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at $52,836 (Q4 2025), $52,620 (Q3 2025) and $52,748 (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 545.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.12 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 192.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.61 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 132.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.58 Bn
10 BioRestorative Therapies 1.36 Mn -17.06 Mn 15,785.00 52,394.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 52,394.00
Dec 31, 2025 52,836.00
Sep 30, 2025 52,620.00
Jun 30, 2025 52,748.00
Mar 31, 2025 51,781.00
Dec 31, 2024 50,369.00
Sep 30, 2024 48,269.00
Jun 30, 2024 47,705.00
Mar 31, 2024 42,713.00
Dec 31, 2023 42,713.00
Sep 30, 2023 42,145.00
Jun 30, 2023 41,526.00
Mar 31, 2023 39,351.00
Dec 31, 2022 31,794.00
Sep 30, 2022 31,225.00
Jun 30, 2022 31,515.00
Mar 31, 2022 26,011.00
Dec 31, 2021 21,496.00
Sep 30, 2021 21,577.00
Jun 30, 2021 21,834.00
API Access

BioRestorative Therapies Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=BRTX&period=max&api_key=YOUR_API_KEY